Health Science Research Roundup: Organoids, Schizophrenia Genetics, and More

Recent health science research highlights include a £20m Cambridge project to grow miniature human organs from NHS patients' cells for drug testing, aiming to improve accuracy and reduce animal testing. Scientists will use these organoids to study disease variability and personalize treatments. Additionally, AI has helped produce one of the most detailed pictures of schizophrenia's genetic architecture, opening new research avenues. Other findings show midlife vascular risk burden is linked to reduced dementia-free survival years, and Louisiana reports a surge in Vibrio vulnificus infections with nine cases and five deaths.